International Society for Hemodialysis™ (ISHD)
Hemodialysis UniversityŽ

October 2 - 3, 2015, Chicago, Illinois USA
     HDCN key zone registration or ISHD membership-at-large is required.
  Part 2. Potassium in Hemodialysis: New Frontiers, and Vascular Access
Optimizing Dialysate Potassium
David Mendelssohn, MD
Novel Potassium Binding Compounds
Stephen R. Ash, MD
Questions and Answers
CVC Simulation: Inserting Central Venous Catheters
Jeffrey H. Barsuk, MD
Questions and Answers

David Mendelssohn, MD
Humber River Regional Hospital
Division of Nephrology
Weston, Ontario

Stephen R. Ash, MD
Indiana University Health Arnett
HemoCleanse, Inc. and
Ash Access Technology, Inc.
Lafayette, Indiana

Jeffrey H. Barsuk, MD
Associate Professor in Medicine
Hospital Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Chicago, Illinois
This educational activity is an audio recording with accompanying slides of a live presentation held on October 2 - 3, 2015, in Chicago, Illinois, USA. Continuing medical education credit is not available for this on-line archive. To view this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from is useful but not necessary to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the slide handouts.

Program Overview
Target Audience
The conference is designed for health professionals involved in dialysis programs, primarily nephrologists, nephrology fellows, nephrology nurses and nurse practitioners, and patient care technicians.

Disclosure Policy
It is the policy of the ISHD and HDCN that speakers with potential conflicts of interest disclose these at the time of presentation.

Off-label/lnvestigational Use
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be "off-label" use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.

The policy statements of HDCN are listed on this page.